FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3178355347> ?p ?o ?g. }

• W3178355347 endingPage "3578" @default.
• W3178355347 startingPage "3566" @default.
• W3178355347 abstract "Pancreatic cancer is uncommon in patients younger than 50 years, although its incidence is increasing. This study characterizes treatment utilization for early-onset pancreatic cancer (EOPC) versus average-age-onset pancreatic cancer (AOPC) and identifies factors associated with failure to receive treatment.The National Cancer Data Base (NCDB) was queried for patients with EOPC (age < 50 years) or AOPC (age ≥ 50 years) from 2004 to 2016. Multinomial regression was used to compare utilization (single modality vs multimodal treatment with or without surgery vs no treatment) between EOPC and AOPC. Kaplan-Meier methods were used to estimate overall survival (OS).Of 248,634 patients, 15,710 (6.3%) had EOPC. There were more male patients (56% vs 50%), non-White patients, and privately insured patients (61% vs 30%) with EOPC versus AOPC, without notable differences in clinical stage distribution. Patients with EOPC received more chemotherapy (38% vs 29%), surgery (9% vs 6.9%), chemoradiation (12% vs 9.2%), and multimodal treatment (21% vs 15%). The odds of receiving multimodal curative therapy were significantly higher for patients with EOPC versus patients with AOPC after adjustments for confounders (odds ratio, 3.89; 95% confidence interval [CI], 3.66-4.15; P < .001). Nineteen percent of patients with EOPC, in contrast to 39% of patients with AOPC, received no treatment. Patients with AOPC more frequently declined chemotherapy (15% vs 9.5%). One-year OS was higher for EOPC versus AOPC across each stage (0/I/II, 72% [95% CI, 71%-74%] vs 53% [95% CI, 53%-54%]; III, 48% [95% CI, 45%-50%] vs 38% [95% CI, 37%-38%]; IV, 25% [95% CI, 24%-26%] vs 15% [95% CI, 15%-15%]) and treated patients (0/I/II, 75% [95% CI, 74%-77%] vs 64% [95% CI, 63%-64%]; III, 51% [95% CI, 49%-54%] vs 47% [95% CI, 47%-48%]; IV, 29% [95% CI, 28%-31%] vs 23% [95% CI, 23%-24%]).Patients with EOPC receive more oncologic therapy than patients with AOPC, although the intensity, type, and duration of chemotherapy are not available in the NCDB; however, 19% and 39%, respectively, receive no therapy. Underutilization may explain suboptimal oncologic outcomes. Efforts to improve access and treatment utilization in all age groups are warranted." @default.
• W3178355347 created "2021-07-19" @default.
• W3178355347 creator A5000216315 @default.
• W3178355347 creator A5009465403 @default.
• W3178355347 creator A5010639886 @default.
• W3178355347 creator A5027467209 @default.
• W3178355347 creator A5038396374 @default.
• W3178355347 creator A5042440032 @default.
• W3178355347 creator A5051277222 @default.
• W3178355347 creator A5058857144 @default.
• W3178355347 creator A5070901426 @default.
• W3178355347 creator A5076438320 @default.
• W3178355347 creator A5079031946 @default.
• W3178355347 date "2021-07-06" @default.
• W3178355347 modified "2023-10-18" @default.
• W3178355347 title "Treatment patterns and survival in patients with early‐onset pancreatic cancer" @default.
• W3178355347 cites W1513618424 @default.
• W3178355347 cites W1973770398 @default.
• W3178355347 cites W1982908661 @default.
• W3178355347 cites W1986249544 @default.
• W3178355347 cites W1986611229 @default.
• W3178355347 cites W1987037453 @default.
• W3178355347 cites W2036654693 @default.
• W3178355347 cites W2067366239 @default.
• W3178355347 cites W2078192409 @default.
• W3178355347 cites W2089937610 @default.
• W3178355347 cites W2095285068 @default.
• W3178355347 cites W2143758437 @default.
• W3178355347 cites W2185110006 @default.
• W3178355347 cites W2342093387 @default.
• W3178355347 cites W2891959586 @default.
• W3178355347 cites W2910527546 @default.
• W3178355347 cites W2912618139 @default.
• W3178355347 cites W2964654360 @default.
• W3178355347 cites W2965010580 @default.
• W3178355347 cites W2998637833 @default.
• W3178355347 cites W3004500220 @default.
• W3178355347 cites W3015255990 @default.
• W3178355347 cites W3042564020 @default.
• W3178355347 cites W3136141454 @default.
• W3178355347 doi "https://doi.org/10.1002/cncr.33664" @default.
• W3178355347 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34228820" @default.
• W3178355347 hasPublicationYear "2021" @default.
• W3178355347 type Work @default.
• W3178355347 sameAs 3178355347 @default.
• W3178355347 citedByCount "17" @default.
• W3178355347 countsByYear W31783553472021 @default.
• W3178355347 countsByYear W31783553472022 @default.
• W3178355347 countsByYear W31783553472023 @default.
• W3178355347 crossrefType "journal-article" @default.
• W3178355347 hasAuthorship W3178355347A5000216315 @default.
• W3178355347 hasAuthorship W3178355347A5009465403 @default.
• W3178355347 hasAuthorship W3178355347A5010639886 @default.
• W3178355347 hasAuthorship W3178355347A5027467209 @default.
• W3178355347 hasAuthorship W3178355347A5038396374 @default.
• W3178355347 hasAuthorship W3178355347A5042440032 @default.
• W3178355347 hasAuthorship W3178355347A5051277222 @default.
• W3178355347 hasAuthorship W3178355347A5058857144 @default.
• W3178355347 hasAuthorship W3178355347A5070901426 @default.
• W3178355347 hasAuthorship W3178355347A5076438320 @default.
• W3178355347 hasAuthorship W3178355347A5079031946 @default.
• W3178355347 hasBestOaLocation W31783553471 @default.
• W3178355347 hasConcept C120665830 @default.
• W3178355347 hasConcept C121332964 @default.
• W3178355347 hasConcept C121608353 @default.
• W3178355347 hasConcept C126322002 @default.
• W3178355347 hasConcept C141071460 @default.
• W3178355347 hasConcept C146357865 @default.
• W3178355347 hasConcept C151730666 @default.
• W3178355347 hasConcept C156957248 @default.
• W3178355347 hasConcept C2776694085 @default.
• W3178355347 hasConcept C2780210213 @default.
• W3178355347 hasConcept C44249647 @default.
• W3178355347 hasConcept C61511704 @default.
• W3178355347 hasConcept C71924100 @default.
• W3178355347 hasConcept C77350462 @default.
• W3178355347 hasConcept C86803240 @default.
• W3178355347 hasConcept C90924648 @default.
• W3178355347 hasConceptScore W3178355347C120665830 @default.
• W3178355347 hasConceptScore W3178355347C121332964 @default.
• W3178355347 hasConceptScore W3178355347C121608353 @default.
• W3178355347 hasConceptScore W3178355347C126322002 @default.
• W3178355347 hasConceptScore W3178355347C141071460 @default.
• W3178355347 hasConceptScore W3178355347C146357865 @default.
• W3178355347 hasConceptScore W3178355347C151730666 @default.
• W3178355347 hasConceptScore W3178355347C156957248 @default.
• W3178355347 hasConceptScore W3178355347C2776694085 @default.
• W3178355347 hasConceptScore W3178355347C2780210213 @default.
• W3178355347 hasConceptScore W3178355347C44249647 @default.
• W3178355347 hasConceptScore W3178355347C61511704 @default.
• W3178355347 hasConceptScore W3178355347C71924100 @default.
• W3178355347 hasConceptScore W3178355347C77350462 @default.
• W3178355347 hasConceptScore W3178355347C86803240 @default.
• W3178355347 hasConceptScore W3178355347C90924648 @default.
• W3178355347 hasFunder F4320337351 @default.
• W3178355347 hasIssue "19" @default.
• W3178355347 hasLocation W31783553471 @default.
• W3178355347 hasLocation W31783553472 @default.

• next